Calendar Evogene Ltd.

Equities

EVGN

IL0011050551

Market Closed - TEL AVIV STOCK EXCHANGE 12:24:08 25/04/2024 BST 5-day change 1st Jan Change
255.1 ILa -1.58% Intraday chart for Evogene Ltd. +8.65% -14.91%

Chart calendar Evogene Ltd.

a0f98571ac2a38dc346.UvC460L6ICgywuS6ICIB4i0-4miDA_OUtjpAoNSJgYI.K7LTnhGdVEdxhqrXGGxQqRxIhR_yZsvs1FwC75fPyM0ZhI_cA7ByRVuIvQ~f0560032a0c6b595e865d4aa426d8213

Upcoming events on Evogene Ltd.

27/05/2024 Q1 2024 Earnings Release (Projected)
03/06/2024 19:30 American Society of Clinical Oncology Annual Meeting - Abstract No: 8631
06/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
05/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Evogene Ltd.

16/03/2024 Roth Conference
07/03/2024 14:00 Q4 2023 Earnings Call
07/03/2024 12:00 Q4 2023 Earnings Release
01/02/2024 16:15 Microbiome Movement Drug Development Summit
30/01/2024 15:30 Microbiome Movement Drug Development Summit
07/01/2024 JPMorgan Healthcare Conference
15/11/2023 14:00 Q3 2023 Earnings Call
15/11/2023 12:00 Q3 2023 Earnings Release
17/08/2023 14:00 Q2 2023 Earnings Call
17/08/2023 12:00 Q2 2023 Earnings Release
18/05/2023 14:00 Q1 2023 Earnings Call
18/05/2023 12:00 Q1 2023 Earnings Release
21/03/2023 14:40 Pharmabiotics Conference
26/05/2021 14:00 Q1 2021 Earnings Call
26/05/2021 12:00 Q1 2021 Earnings Release
21/04/2021 Jefferies Microbiome-based Therapeutics Summit
21/04/2021 14:00 Investor & Analyst Day
03/03/2021 14:00 FY 2020 Earnings Call
03/03/2021 12:00 FY 2020 Earnings Release
23/01/2021 19:00 Crohn & Colitis Congress

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


1,04
0,00
-
0,93
0,61
51.47%
1,68
1,57
6.69%
5,64
5,54
1.86%

17,0

EBITDA
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-22,0
-21,8
-0.92%

-17,7

EBIT
Million USD
Released
Forecast
Spread
0,00


-24,8
-24,0
-3.39%
-31,0
-28,9
-7%
-26,9
-31,8
15.39%
-26,5
-26,4
-0.49%

-22,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-26,2
-23,0
-13.8%
-30,4
-30,6
0.52%
-29,8
-34,0
12.49%
-26,0
-26,0
0.09%

-22,9

Net income
Million USD
Released
Forecast
Spread
-18,1


-23,4
-23,0
-1.63%
-27,8
-29,0
4.18%
-26,6
-31,2
14.73%
-23,9
-25,0
4.59%

-20,9

EPS
USD
Released
Forecast
Spread
-0,70


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date04/03/2003/03/2110/03/2209/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,31
0,17
85.48%
0,24
0,31
-23.3%
0,31
0,22
41.39%
0,47
0,28
65.25%
0,66
0,55
20%
0,64
0,69
-6.42%
0,65
0,89
-26.1%
3,77
1,18
218.34%
0,58
0,48
21.68%

3,50


2,50


8,00


3,00


2,50

EBITDA
Million USD
Released
Forecast
Spread















-5,74
-5,95
3.58%
-6,45
-6,05
-6.66%
-2,98
-6,30
52.75%
-6,85
-6,33
-8.33%

-3,55


-5,33


-3,50


-5,35




EBIT
Million USD
Released
Forecast
Spread
-8,69
-8,71
0.21%
-8,06
-8,09
0.41%
-8,01
-8,21
2.49%
-7,10
-8,70
18.38%
-3,78
-8,75
56.78%
-6,80
-7,85
13.37%
-7,90
-7,98
0.93%
-4,18
-7,67
45.46%
-7,63
-7,49
-1.88%

-4,85


-6,63


-4,80


-6,65




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,09
-8,57
5.6%
-9,10
-8,75
-4.08%
-9,72
-8,29
-17.17%
-7,16
-8,38
14.56%
-3,78
-8,00
52.8%
-7,03
-7,10
1.04%
-7,76
-7,98
2.73%
-3,86
-7,64
49.42%
-7,34
-7,34
-0.05%

-4,85


-6,63


-4,80


-6,65




Net income
Million USD
Released
Forecast
Spread
-7,37
-8,16
9.64%
-9,11
-7,61
-19.72%
-8,82
-7,71
-14.45%
-6,54
-8,46
22.69%
-3,00
-8,28
63.79%
-6,27
-7,60
17.43%
-7,02
-7,29
3.66%
-3,98
-7,21
44.77%
-6,60
-7,09
6.86%

-4,35


-6,13


-4,30


-6,15




Announcement Date10/03/2226/05/2231/08/2217/11/2209/03/2318/05/2317/08/2315/11/2307/03/24-----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise